Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype
Pascal Jézéquel, Hamza Lasla, Wilfried Gouraud, Agnès Basseville, Bertrand Michel, Jean‐Sébastien Frenel, Philippe Juin, Fadoua Ben Azzouz, Mario Campone
Topics & Concepts
MedicineTriple-negative breast cancerSurgical oncologyBreast cancerImmune systemOncologyTriple negativeMesenchymal stem cellInternal medicineCancerCancer researchBioinformaticsPathologyImmunologyBiologyCancer Immunotherapy and BiomarkersBreast Cancer Treatment StudiesImmunotherapy and Immune Responses